Advertisement
Home 2015

Archives

Prices at hospitals in monopoly markets are 15 percent higher than those at hospitals in areas with at least four providers

Higher Hospital Prices in U.S. ‘Monopoly Markets’

0
Hospital prices positively associated with indicators of hospital market power
Zurampic (lesinurad) has been approved by the U.S. Food and Drug Administration to control blood levels of uric acid associated with gout.

FDA Approves Zurampic for the Treatment of Gout

0
Drug helps control blood levels of uric acid
The U.S. Preventive Services Task Force (USPSTF) has found that current evidence is insufficient for determining the balance of benefits and harms of lipid disorder screening in children

Two Draft Statements From USPSTF Open for Comment

0
Insufficient evidence for lipid screening in children; recommendation for statins varies with age, risk
Men who have sex with men who have abstained from sex for one year will now be allowed to donate blood in the United States. The new policy

FDA Lifts Ban on Blood Donations by Men Who Have Sex With Men

0
National blood surveillance system will help agency ensure safety of the blood supply
Uptravi (selexipag) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension.

FDA Approves Uptravi for Pulmonary Arterial Hypertension

0
Drug found to limit worsening of the disease and reduce the need for hospitalization
More than half of U.S. states are poorly prepared to respond to infectious disease outbreaks

Over Half of U.S. States Ill Prepared for Disease Outbreaks

0
Efforts needed to boost ability to respond to viruses, superbug threats
The Fenix Continence Restoration System has been approved by the U.S. Food and Drug Administration to treat an inability to control bowel movements for patients who can't tolerate or use other approved methods.

FDA Approves New Device for Fecal Incontinence

0
Viable surgical option when medical measures have failed
The LifeVest wearable defibrillator has been approved by the U.S. Food and Drug Administration for children at risk for cardiac arrest who can't have a defibrillator implanted. The device is already approved for adults.

FDA Approves LifeVest Wearable Defibrillator for Children

0
For heart patients who can't have device implanted
Bridion (sugammadex) has been approved by the U.S. Food and Drug Administration to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide.

FDA Approves Bridion to Reverse Neuromuscular Blockade

0
Drug reverses the effects of rocuronium bromide and vecuronium bromide
All adults and teens at increased risk for syphilis should be screened for the sexually transmitted disease

USPSTF: Screen All Teens, Adults at Risk for Syphilis

0
Proposed recommendation dovetails with surge in U.S. cases of the sexually transmitted disease